Intrinsiqq
Zhengye Biotechnology Holding Ltd. logo

Zhengye Biotechnology Holding Ltd. Dividend Analysis

ZYBT

⊜ Compare
Dividend0
No current dividend

This company does not have a meaningful dividend profile under this framework.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

0

Safety

40% of composite

Earnings Payout0
N/ANot reported
FCF Coverage0
N/ANo data
0

Growth

35% of composite

Dividend Streak0
0YNo sustained streak
Growth Rate0
-14.9%Declining
0

Income

25% of composite

Cash Yield (TTM)0
N/ANo data

Composite = Safety (0) × 0.40 + Growth (0) × 0.35 + Income (0) × 0.25 = 0

Dividend Safety

Earnings Payout

Not reported

FCF Payout

0.0%

FCF Coverage

–

Dividend Growth

Per Share (TTM)

CNY 0.00

Growth Streak

–

2Y CAGR

-14.9%

Dividend history

Dividend per share by fiscal year
Fiscal yearPer shareChange
2024CNY 0.34-60.7%
2023CNY 0.86+84.1%
2022CNY 0.47

All 3 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Does Zhengye Biotechnology Holding (ZYBT) pay a dividend?

Frequently asked

Does Zhengye Biotechnology Holding (ZYBT) pay a dividend?+

No. Zhengye Biotechnology Holding (ZYBT) does not currently pay a dividend. The last payment in our data was in 2024, and nothing has been paid since.

How does Zhengye Biotechnology Holding return cash to shareholders?+

It largely does not. Zhengye Biotechnology Holding pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Zhengye Biotechnology Holding afford to pay a dividend?+

On the numbers, yes. Zhengye Biotechnology Holding generated CNY 703,000.00 of free cash flow, which is about CNY 0.01 per share. If it paid out half of that, the dividend would be roughly CNY 0.01 per share, a yield of about 0.5% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Zhengye Biotechnology Holding.

Peers

Drug Manufacturers - Specialty & Generic · Pick stocks to compare with ZYBT

CompareIntrinsic value
MAK.XETRMaternus-Kliniken Aktiengesellschaft
€0.86-2.84%61
CONTX.XOSLContextVision AB
kr 4.43-2.64%36
AZT.XOSLArcticZymes Technologies ASA
€2.05+1.99%23
MDXHMDxHealth SA
$0.16-1.01%30
REG1V.XHELRevenio Group Oyj
€10.32+0.10%51
SEZI.XSTOSenzime AB
€0.28+2.02%40
GENO.XSTOGenovis AB
€1.88+0.32%53
TALEA.XMILTalea Group S.p.A.
No recent price33

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ZYBT

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.